LBF22506SC01: Difference between revisions
No edit summary |
No edit summary |
(No difference)
|
Revision as of 06:00, 15 April 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | DFA0221 |
LipidMaps | LMFA01030182 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF22506SC01 |
4, 7, 10, 13, 16-Docosapentaenoic acid | |
---|---|
Structural Information | |
4, 7, 10, 13, 16-Docosapentaenoic acid | |
| |
C22:5n-6 / C22:5 omega 6 | |
Formula | C22H34O2 |
Exact Mass | 330.255880332 |
Average Mass | 330.50416000000007 |
SMILES | C(CCC(O)=O)=CCC=CCC=CCC=CCC=CCCCCC |
Physicochemical Information | |
soluble in chloroform, heptane and methyi alcohol. | |
Brain phosphatides. | |
The synthesis of 4,7,10,13,16-22:5 occurs via the following reaction sequence Sprecher_H et al.: 9,12-18:2 --> 6,9,12-18:3 --> 8,11,14-20:3 --> 5,8,11,14-20:4 --> 7,10,13,16-22:4 --> 9,12,15,18-24:4 --> 6,9,12,15,18-24:5 --> 4,7,10,13,16-22:5. According to these pathways the 24-carbon acids that are made in the endoplasmic reticulum move to a site for partial beta-oxidation, which is most likely peroxisomes. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|